E
LFMD icon

Ergoteles’s LifeMD LFMD Stock Holding History

Ergoteles’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,500
Closed -$171K – 1472
2021
Q2 		$171K Buy
+14,500
New +$167K ﹤0.01% 1324

Other funds holding LFMD

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Ergoteles's LFMD Position: Q3 2021 in Review

Ergoteles sold out of LifeMD (LFMD) in Q3 2021, closing a stake of 14,500 shares — an estimated $171K sold.

Ergoteles first reported a position in LFMD in Q2 2021 and held it in 1 quarter. The position peaked at $171K in Q2 2021. 69 funds tracked by Wall St. Rank hold LFMD as of Q3 2021.

  • Ergoteles reported no remaining LifeMD position as of Q3 2021 after selling out during the quarter.
  • Ergoteles sold 14,500 LifeMD shares in Q3 2021, an estimated $171K.
  • Ergoteles first reported a position in LifeMD in Q2 2021 and held it in 1 quarter.
  • Ergoteles's LifeMD position peaked at $171K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held LifeMD as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.